Alexander Ford compensation by year
MYRIAD GENETICS Summary Compensation Table · all 4 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Salary | $499,200 | $499,200 | $519,168 | $513,271 |
| Bonus | $307 | $0 | $200 | $0 |
| Stock awards | $1,314,000 | $1,954,200 | $2,392,500 | $1,496,500 |
| Option awards | $0 | $0 | $0 | $0 |
| Non-equity incentive | $245,606 | $296,525 | $293,226 | $150,643 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $10,848 | $11,020 | $26,608 | $22,629 |
| Total | $2,069,961 | $2,760,945 | $3,231,702 | $2,183,043 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MYRIAD GENETICS INC DEF 14A filed October 15, 2020, accession 0001193125-20-269774, and prior-year filings. Open the filing on EDGAR.
How this page was built: the MYRIAD GENETICS INC filed document, accession 0001193125-20-269774. Every figure is read from that document and cited to the page and table it appears in. Filed October 15, 2020.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 50,000 | $1,389,000 | — |
| RSU | 45,000 | $1,250,100 | — |
| RSU | 30,000 | $833,400 | — |
| RSU | 4,125 | $114,593 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in MYRIAD GENETICS INC's FY2019 proxy; value at the fiscal year-end close, as the company printed it.
MYRIAD GENETICS’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Paul Diaz | President and Chief Executive Officer | $15,500,821 |
| Mark Capone | Former President and Chief Executive Officer and Director | $6,174,458 |
| R. Bryan Riggsbee | Chief Financial Officer and Treasurer; Interim President and Chief Executive Officer | $4,203,341 |
| Alexander Ford · this page | Former Chief Operating Officer | $2,183,043 |
| Gary King | Former Executive Vice President International Operations | $1,961,159 |
| Bernard Tobin | Former President of Myriad Autoimmune | $1,879,045 |
| Jerry Lanchbury | Chief Scientific Officer | $1,829,238 |
| Nicole Lambert | Women’s Health, Oncology, and International | $1,704,706 |
The full MYRIAD GENETICS compensation record
free company briefThis page is one person within MYRIAD GENETICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the MYRIAD GENETICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MYRIAD GENETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.